Steroid dependent ulcerative colitis: Azathioprine use is finally "evidence-based"

Inflammatory Bowel Diseases

Volumn 12, Issue 9, 2006, Pages 921-922

  Ginsburg, Philip M ^a   Dassopoulos, Themistocles ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MESALAZINE; OLSALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG USE; EVIDENCE BASED PRACTICE; HUMAN; NOTE; PRIORITY JOURNAL; ULCERATIVE COLITIS; UNSPECIFIED SIDE EFFECT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AZATHIOPRINE; COLITIS, ULCERATIVE; HUMANS; MESALAMINE; SINGLE-BLIND METHOD; STEROIDS;

EID: 33748465116     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.mib.0000242277.10770.b9     Document Type: Note

References (0)